XJZY(SZ:002332)2016-10-27 16:00Financial Performance - Net profit attributable to shareholders was ¥41,697,489.11, representing a significant increase of 38.84% year-on-year[8]. - Operating revenue for the period was ¥616,568,897.65, a decrease of 7.18% compared to the same period last year[8]. - The net profit after deducting non-recurring gains and losses was ¥43,768,693.60, up 49.79% year-on-year[8]. - Basic earnings per share increased by 16.67% to ¥0.07[8]. - The net profit attributable to shareholders for 2016 is expected to range from CNY 138.52 million to CNY 159.83 million, representing a growth of 30% to 50% compared to the previous year[22]. - The net profit for 2015 was CNY 106.55 million, with the increase primarily driven by a rise in gross margin due to lower raw material costs[23]. - The increase in profit is attributed to improved product gross margins due to decreased raw material costs[23]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥3,518,574,121.15, an increase of 2.32% compared to the previous year[8]. - Accounts receivable increased by 67.06%, up by 26,985.68 million CNY, mainly due to stable operating income and structural reasons[16]. - Other receivables increased by 50.48%, up by 1,850.73 million CNY, primarily due to an increase in other temporary payments[16]. - Construction in progress increased by 75.1%, up by 9,433.24 million CNY, mainly due to increased investment in engineering projects[16]. - Long-term borrowings decreased by 100%, down by 8,375 million CNY, mainly due to repayments and reclassification of long-term borrowings due within one year[16]. - Accounts payable increased by 35.31%, up by 6,496.3 million CNY, mainly due to total purchases exceeding payments[16]. Cash Flow - The company reported a net cash flow from operating activities of ¥52,242,774.23, an increase of 36.92% year-to-date[8]. - Cash received from tax refunds decreased by 74.9%, down by 291.39 million CNY, mainly due to last year's export tax rebate from Haisheng Pharmaceutical[16]. - Cash received from other operating activities increased by 31.9%, up by 535.06 million CNY, mainly due to increased interest income[16]. - Cash paid for investments decreased by 59.09%, down by 1,878 million CNY, mainly due to reduced external investments[16]. Shareholder Information - The total number of shareholders at the end of the reporting period was 30,794[12]. - The largest shareholder, Xianju County State-owned Assets Investment Group, holds 21.55% of the shares[12]. - The company has committed to not transferring 20,223,964 new shares for 36 months following the listing of the new shares[19]. - The company will also not transfer 5,055,991 new shares for 36 months after their listing[20]. Compliance and Governance - There are no violations regarding external guarantees during the reporting period[24]. - There are no non-operating fund occupations by controlling shareholders or related parties during the reporting period[25]. - The company adheres to relevant regulations regarding stock issuance and management practices[19]. Investor Relations - The company has conducted multiple investor relations activities, including site visits on July 14, July 21, and September 8, 2016[26]. - The company is expected to maintain a positive net profit without being in a turnaround situation for the fiscal year 2016[22]. - The company did not engage in any repurchase transactions during the reporting period[13]. Financial Expenses and Income - Financial expenses decreased by 46.75%, down by 2,016.02 million CNY, mainly due to reduced loan amounts from raised funds[16]. - Investment income decreased by 81.93%, down by 767.57 million CNY, primarily due to a decline in subsidiary operating performance[16].